Are you Dr. Forthal?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 52 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Uci Medical Center
Orange, CA 92868Phone+1 714-456-8978
Summary
- Dr. Donald N Forthal, MD is an infectious disease specialist in Orange, California. He is currently licensed to practice medicine in California and Georgia. He is affiliated with UCI Health and is an Associate Professor of Medicine at UC Irvine.
Education & Training
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Pediatrics, 1982 - 1984
- Los Angeles County-Harbor-UCLA Medical CenterResidency, Pediatrics, 1979 - 1982
- University of California, Irvine, School of MedicineClass of 1979
Certifications & Licensure
- CA State Medical License 1981 - 2026
- GA State Medical License 1985 - 1989
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:San Diego Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
Publications & Presentations
PubMed
- Impact of Human Leukocyte Antigen Allele-Killer Cell Immunoglobulin-like Receptor Partners on Sexually Transmitted Human Immunodeficiency Virus Type 1 Infection.Carmen Serrano-Rísquez, Mohamed Omar, Norma Rallón, José Miguel Benito, Amparo Gómez-Vidal
The Journal of Infectious Diseases. 2024-11-15 - 2 citationsOutpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial.Han-Sol Park, Anna Yin, Caelan Barranta, John S Lee, Christopher A Caputo
JCI Insight. 2024-03-14 - A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogeni...Swayam Prakash, Nisha R Dhanushkodi, Mahmoud Singer, Afshana Quadiri, Latifa Zayou
Biorxiv. 2024-02-15
Grant Support
- Rodent Animal Biosafety Level 3 (ABSL3)National Institute Of Allergy And Infectious Diseases2009–2012
- Pswrce Cpmprehensive Program Training Program For High Containment LABNational Institute Of Allergy And Infectious Diseases2009–2012
- Iron Starvation: A Novel Strategy For HIV And Chlamydia MicrobicidesNational Institute Of Allergy And Infectious Diseases2011
- Broadly Reactive Antibodies Against Chimeric Virus-Host AntigensNational Institute Of Allergy And Infectious Diseases2010–2011
- Iron Starvation: A Novel Strategy For HIV And Chlamydia MicrobicidesNational Institute Of Allergy And Infectious Diseases2009–2010
- CntnNational Center For Research Resources2004–2010
- Protective Immunity Against HIV: The Role Of IGG Subclass And GlycosylationNational Institute Of Allergy And Infectious Diseases2008–2009
- Fcy Receptor Polymorphisms And Risk Of HIV InfectionNational Institute Of Allergy And Infectious Diseases2007–2008
- Novel Biological Activities Of Anti-Viral AntibodyNational Institute Of Allergy And Infectious Diseases2002–2006
- Protective Immunity Against Breast CancerNational Center For Research Resources2004
- Immunoprophylaxis--Defining Protective Antibody FunctionNational Institute Of Allergy And Infectious Diseases1999–2001